Maria Markopoulou

Dr. Maria Markopoulou

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2002 in Aging Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
AIApostolos Iacovides
Apostolos Iacovides
Konstantinos N FountoulakisKonstantinos N Fountoulakis
Konstantinos N Fountoulakis
EBEvangelos Balaskas
Evangelos Balaskas
AMAikaterini Manika
Aikaterini Manika
MMMaria Markopoulou
Maria Markopoulou
ATAchileas Tourkantonis
Achileas Tourkantonis

1 July 2021 in Journal of Forensic and Legal Medicine
Verified
Journal Article
Closed access
MKMaria-Valeria Karakasi
Maria-Valeria Karakasi
ENEvangelos Nastoulis
Evangelos Nastoulis
KZKonstantinos Zisopoulos
Konstantinos Zisopoulos
MMMaria Markopoulou
Maria Markopoulou
MAMaria Alexandri
Maria Alexandri
PPPavlos Pavlidis
Pavlos Pavlidis

1 September 2008 in General Hospital Psychiatry
Verified
Journal Article
Closed access
PAPetros Angelopoulos
Petros Angelopoulos
MMMaria Markopoulou
Maria Markopoulou
KKKyriakos Kyamidis
Kyriakos Kyamidis
KBKonstantinos Bobotas
Konstantinos Bobotas

5 June 2017 in Journal of Forensic Sciences
Verified
Journal Article
Closed access
PDF file
MKMaria‐Valeria Karakasi
Maria‐Valeria Karakasi
MMMaria Markopoulou
Maria Markopoulou
ITIoannis K. Tentes
Ioannis K. Tentes
PTPanagiotis N. Tsikouras
Panagiotis N. Tsikouras
EVEpameinondas Vasilikos
Epameinondas Vasilikos
PPPavlos Pavlidis
Pavlos Pavlidis

22 July 2022 in Diseases
Verified
Journal Article
Open access
PDF file
EPEvangelia Papatriantafyllou
Evangelia Papatriantafyllou
DEDimitris Efthymiou
Dimitris Efthymiou
MMMaria Markopoulou
Maria Markopoulou
ESEfthymia-Maria Sakellariou
Efthymia-Maria Sakellariou
Emilia VassilopoulouEmilia Vassilopoulou
Emilia Vassilopoulou
(1) Background: The second-generation antipsychotics (SGAPs) induce metabolic and inflammatory side effects, but documentation of their effects on the liver and kidneys is scarce. Aim: To study the three-year fluctuation of selected markers of renal and hepatic function in forensic psychiatric patients receiving SGAPs for more than five years. (2) Methods: Thirty-five forensic psychiatric patients (N = 35) were classified into two groups according to the type of SGAPs used for their treatment and the relevant risk of weight gain and metabolic complications. The three-year medication history, anthropometric data and biochemical data relevant to renal and hepatic function were retrieved from the individual medical files, specifically: serum levels of urea, uric acid, creatinine, alkaline phosphatase and amylase; the liver function enzymes, serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT) and gamma-glutamyl transpeptidase(γ-GT), and also the inflammatory index C-reactive protein (CRP). (3) Results: The patients receiving the SGAPs with a low risk for weight gain showed no significant fluctuation in the biochemical markers over the three-year period. The patients receiving the SGAPs with a high risk for weight gain showed significant differences between at least two measurements of uric acid (p = 0.015), SGOT (p = 0.018) and SGPT (p = 0.051). They showed significantly higher levels of creatinine in the third year compared to the second year (p = 0.029), and SGOT in the second year compared to the first (p = 0.038), and lower levels of SGPT in the third year compared to the second (p = 0.024). (4) Conclusion:In addition to consideration of possible metabolic and inflammatory complications, the choice of an antipsychotic drug for long-term treatment should also take into account the risk of hepatotoxicity and kidney damage.

1 June 2022 in Medicine, Science and the Law
Verified
Journal Article
Closed access
MKMaria-Valeria Karakasi
Maria-Valeria Karakasi
PVPolychronis Voultsos
Polychronis Voultsos
EFEleni Fotou
Eleni Fotou
INIoannis Nikolaidis
Ioannis Nikolaidis
MKMaria Sofia Kyriakou
Maria Sofia Kyriakou
PPPavlos Pavlidis
Pavlos Pavlidis
Temporal trends in epidemiological parameters of domestic homicide and femicide in Greece over the last decade have not yet been studied. We conducted this study to fulfill this purpose. Specifically, we conducted a retrospective epidemiological study using 11-year data from the official nationwide Hellenic Police Archives and statistically analyzed data regarding domestic homicide and femicide. Overall, 1370 records of homicides among which 236 domestic homicides were identified. The pattern emerging from the statistical results of the present study highlighted the phenomenon of femicide as the gravest current issue to be interpreted and addressed. Nationally, the average number of homicides was 114.2/year, among which 19.7 domestic homicides. However, in 2021, while a decrease was recorded in homicides in general to 89 incidents per year, domestic homicides skyrocketed to 34 cases, reaching the highest annual number ever nationally recorded. On average, domestic homicides account for 18.2% of all homicides in Greece. In 2021, however, this percentage rose to 38.2%. The number of male victims of domestic homicide has declined over the years, with a further decline in 2021, in stark contrast to the number of women escalating over time and even more sharply in 2021. The proportion of female victims of domestic homicides in Greece was fourfold higher on average. The fact that cases of domestic homicide and femicide have received a lot of media attention, the recent Greek financial crisis, as well as increased alcohol and drug consumption due to the COVID-19 pandemic constitute possible aggravating factors.